Cingulate Inc Warrants
Price & Volume
Stats
See more52W Range | $0.007-$0.18 |
Shares Short | 1,903 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.73 |
News
See moreYahoo Finance • last year
Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023
About
CEO | Dr. Shane J. Schaffer Pharm.D. |
CFO | Ms. Jennifer L. Callahan CPA |
Address | 1901 West 47th Place, Kansas City, KS, United States, 66205 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
